Oral cancer is a growing public health concern, particularly in South Asia, where it affects tens of thousands each year. In ...

Viewing lupus decision aids without interruption leads to better patient-reported outcomes, regardless of whether they are ...

Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

Background/ Purpose Belimumab was approved for the treatment of non-renal SLE in 2011 and has been previously associated with a lower risk of damage progression when compared with prior ‘usual care.’ ...

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.